Line Malha, MD

Dr. Mary E. Choi is a Professor of Medicine at Weill Cornell Medical College (WCMC) and an Attending Physician at NewYork-Presbyterian Hospital. Dr. Choi received her medical degree from the University of Kansas School of Medicine. She completed residencies at the University of California San Francisco and VAMC and Duke University Medical Center. She was a Clinical and Research Fellow in Nephrology at the Johns Hopkins School of Medicine.Dr. Choi is a National Institute of Health (NIH) funded physician scientist whose expertise includes cellular and molecular mechanisms of kidney injury, inflammation and fibrosis, TGF beta signaling and autophagy. She serves on several committees in the WCMC Department of Medicine including the Medicine Ground Rounds Award Committee, Research Executive Committee and the Medicine Research Retreat Program Committee.She is the Director of the Basic Science Research Core Curriculum in the Internal Medicine Residency Program. Dr. Choi is also a permanent member of the NIH Study Section, Molecular and Integrative Signal Transduction (MIST) and an Editorial Board Member of the Kidney Research & Clinical Practice in Physiological Reports.

Darshana Dadhania, M.D., M.S., D(ABHI) is an Associate Professor of Medicine at the Weill Cornell Medical College and an Associate Attending Physician at the NewYork-Presbyterian Hospital. She also holds several administrative positions to include: Medical Director of Kidney and Pancreas Transplant Program; Program Director of Transplant Nephrology Fellowship at NewYork-Presbyterian/Weill Cornell. She is board certified in Internal Medicine and Nephrology. Dr. Dadhania received her MD from the University of Medicine and Dentistry of NJ and completed her internal medicine residency, nephrology fellowship, and transplant medicine fellowship at NewYork-Presbyterian Hospital. Following her transplant medicine fellowship, Dr. Dadhania received additional training in histocompatibility testing and received her New York state laboratory license for histocompatibility testing and her Diplomate of American Board of Histocompatibility and Immunogenetics. She is currently the Director of Genomics Division and Associate Director of the Immunogenetics and Transplantation Center.Dr. Dadhania is an active clinician, investigator, and mentor. Her academic career has focused on development of diagnostic and prognostic noninvasive biomarkers for long-term success of kidney allografts and management of highly sensitized kidney transplant patients and infectious complications post-transplant. She has received advanced training in research methodology and graduated from the Weill Cornell Graduate School of Medical Sciences with a Master's degree in clinical and translational investigation. She has served as the site Principal Investigator for NIH supported Clinical Trials in Organ Transplantation (CTOT)-03 and CTOT-04 and is currently a multiple Principal Investigator for North East Consortium for Transplant Outcomes in APOL1 Kidney Recipients and Metagenomic Profiling of Urinary cell-free DNA to Monitor Urinary Tract Infection after Kidney Transplantation.She has become a nationally recognized leader in the field of transplantation through her role as the Chair of Kidney Pancreas Community of Practice of the American Society of Transplantation and has co-Chaired several consensus conferences: (1) Frailty in solid organ transplant recipients, (2) Cardiovascular disease in solid organ transplant recipients, and (3) Heart-Kidney transplantation. She also serves on the international editorial board of Nephrology, Dialysis and Transplantation journal and Transplantation journal.

Shivani Daryani is a native New Yorker, who received her Master of Science in Health Sciences for Physician Assistants (MSHS PA) at Weill Cornell Graduate School of Medical Sciences. She previously worked as an inpatient neurology PA at Lenox Hill Hospital, with a primary focus in stroke neurology. In 2021, she joined the neurology department at Weill Cornell Medical College. She is primarily involved with the department's outpatient stroke care initiatives, including 1) The RESCUE TIA Clinic, which focuses on providing rapid, comprehensive outpatient evaluation and management of patients with a recent TIA or minor, non-disabling, stroke; 2) The Transitions of Care Clinic, which ensures that patients discharged from the ER/hospital with stroke/TIA have an opportunity to follow-up within 2 weeks for urgent, standardized care; 3) and all other functions of the outpatient stroke clinic. Shivani is dedicated to building a strong relationship with her patients and promoting the importance of secondary stroke prevention.